Gunjan Sharma

Gunjan Sharma is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as the Director of US Oncology/Hematology Access Marketing at Bristol Myers Squibb since October 2022, focusing on access marketing for Multiple Myeloma products including Revlimid, Pomalyst, and Empliciti. Prior experience includes a directorial role in Global Pricing and Market Access at Amgen, where responsibilities encompassed integrated access strategy for multiple product launches across various therapeutic areas. Gunjan has also held management positions in payer marketing at Forest Laboratories and worked as an associate consultant at Covance Market Access Services, along with gaining initial experience as an MBA intern at Genentech. Academic credentials include an MBA in Marketing from Duke University's Fuqua School of Business and a Bachelor of Dental Surgery from Rajiv Gandhi University of Health Sciences.